$0.022300
0.006339.38%
Pre-Market: Sep 19, 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Infinity Pharmaceuticals Inc (OTC:INFI) Stock
Infinity Pharmaceuticals Inc Stock (OTC: INFI)
Categories: All
Wednesday, September 13, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Infinity Pharmaceuticals Received A Delisting...
Tuesday, August 29, 2023
Friday, August 25, 2023
Thursday, August 17, 2023
Wednesday, August 09, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Tuesday, August 08, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Infinity Pharmaceuticals shares are trading h...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Monday, August 07, 2023
Wednesday, July 26, 2023
Monday, July 24, 2023
- Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why Infinity Pharmaceuticals (INFI) Stock Is Getting Obliterated
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Infinity Pharmaceuticals shares are trading l...
- Infinity Pharmaceuticals Announces Terminatio...
- Why AMC Entertainment Holdings Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket
- Sunday, MEI Pharma Did Not Obtain Necessary S...
- MEI Pharma Fails To Secure Stockholder Approv...
Monday, July 17, 2023
Monday, July 10, 2023
- Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger
- Infinity Pharmaceuticals Provides Additional Information On MARIO-8 Study Evaluating Eganelisib In Combination With The PD-1 Targeted Checkpoint Inhibitor Pembrolizumab In Patients With Squamous Cell Cancer Of The Head And Neck